Economic Atlas
Companies/Eden Empire Inc.
Company profile

Eden Empire Inc.

OTC: EDNEF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#1019 of 1,422 Healthcare companies by revenue
EA Score
——
Revenue TTM
$171.0k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$3.1M
Employees
—
as of 2026-08-03
Market cap
$68.6k
as of 2026-08-03

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$171.0k217.9k CAD2021
Net income-$3.1M-4.0M CAD2021
Operating income-$2.3M-2.9M CAD2021
Total assets$3.5M4.4M CAD2021
Liabilities$3.3M4.1M CAD2021
Equity$107.3k133.7k CAD2021

Revenue trend

FY2019 – FY2021 · USD
FY19
FY20
FY21

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Eden Empire Inc.’s revenue?

Eden Empire Inc. booked $171.0k in FY2021 revenue — among the slowest-growing Healthcare companies we track, at a -1818.9% net margin.

Peers · Healthcare
Panacos Pharmaceuticals, Inc.——Appili Therapeutics Inc28DMedMira Inc.31DLisata Therapeutics, Inc.39DInnerScope Hearing Technologies, Inc.——Kalaris Therapeutics Inc30D
Key facts
CEODavid Gdanski
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: EDNEF
Employees—
IPO date2021-08-19
Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.